Nitric oxide (NO)- and nitroxyl (HNO)-generating diazeniumdiolates (NONOates): emerging commercial opportunities.
about
Gene expression profiles of NO- and HNO-donor treated breast cancer cells: insights into tumor response and resistance pathwaysStabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and Double JS-K, through incorporation into PEG-protected nanoparticlesNitric oxide nanoparticle technology: a novel antimicrobial agent in the context of current treatment of skin and soft tissue infectionPhotoactive Ruthenium Nitrosyls: Effects of Light and Potential Application as NO Donors.Tailored Synthesis of Nitric Oxide-Releasing Polyurethanes Using O-Protected Diazeniumdiolated Chain Extenders.Analysis of the HNO and NO donating properties of alicyclic amine diazeniumdiolates.Nanocarriers for nitric oxide delivery.Chemotherapeutic potential of diazeniumdiolate-based aspirin prodrugs in breast cancer.Nitric oxide release: part II. Therapeutic applications.Synthesis and in vitro anti-leukemic activity of structural analogues of JS-K, an anti-cancer lead compound.Xerogel optical sensor films for quantitative detection of nitroxylAryl bis(diazeniumdiolates): potent inducers of S-glutathionylation of cellular proteins and their in vitro antiproliferative activitiesSynthesis, nitric oxide release, and anti-leukemic activity of glutathione-activated nitric oxide prodrugs: Structural analogues of PABA/NO, an anti-cancer lead compoundSynthesis, mechanistic studies, and anti-proliferative activity of glutathione/glutathione S-transferase-activated nitric oxide prodrugs.Decoding nitric oxide release rates of amine-based diazeniumdiolates.Nitric oxide and cancer therapy: the emperor has NO clothesSynthesis and chemical and biological comparison of nitroxyl- and nitric oxide-releasing diazeniumdiolate-based aspirin derivativesPhoto-crosslinked Biodegradable Elastomers for Controlled Nitric Oxide DeliveryNitric oxide-donating materials and their potential in pharmacological applications for site-specific nitric oxide delivery.The potential of nitric oxide releasing therapies as antimicrobial agents.Use of nitric oxide nanoparticulate platform for the treatment of skin and soft tissue infections.Light-triggered nitric oxide delivery to malignant sites and infection.Mechanistic studies on the reaction between R2N-NONOates and aquacobalamin: evidence for direct transfer of a nitroxyl group from R2N-NONOates to cobalt(III) centersRuthenium nitrosyls derived from tetradentate ligands containing carboxamido-N and phenolato-o donors: syntheses, structures, photolability, and time dependent density functional theory studiesSyntheses, structures, and photochemistry of manganese nitrosyls derived from designed Schiff base ligands: potential NO donors that can be activated by near-infrared light.The Nitric Oxide Prodrug V-PROLI/NO Inhibits Cellular Uptake of Proline.Antimicrobial efficacy and wound-healing property of a topical ointment containing nitric-oxide-loaded zeolites.Combination of betulinic acid with diazen-1-ium-1,2-diolate nitric oxide moiety donating a novel anticancer candidate.Nitric oxide release triggered by two-photon excited photoluminescence of engineered nanomaterials.
P2860
Q26821895-58280585-D572-481D-B17D-AF7D1C4D7EACQ33624748-BBC4174C-4A5C-4837-B40C-2C290EB249D0Q34066198-2D633199-4B2F-401D-BDF7-B6E34F37DB74Q34259551-9A94013C-8FE0-4D41-8FE6-944C7826F1ACQ34365238-DDBF54B9-0306-46D5-A117-016BF5121779Q34646634-3D5C1625-07B2-4E55-8E3F-349DCC8BD6A9Q35176430-BD8E80C8-C421-44E3-850A-0C721326E27DQ35638851-9669DD1E-4373-406C-B949-0069A8CA14D3Q35926097-8C0F458B-951B-4B21-AFFE-3DF30B62DCA3Q36516264-783B8BC9-98AB-49F8-8F5C-7780E3B956BFQ36580222-853C220A-3017-4302-9047-D650D7647CF9Q37070223-AAD1F080-3988-497D-922B-2A0AB0C298E9Q37074663-557F6770-8070-4476-9C25-7CBCF5A3305CQ37074670-8BBB6D16-3928-450F-B112-B5A61A8EAB07Q37149496-16F35F99-BDD1-488E-86D7-9C19BFA42454Q37195118-3F7B3ECB-120D-42DD-BF77-62F817438596Q37432633-DD230DB8-12CE-4172-AF27-D9A67CA61F76Q37678182-74D426FF-8D26-4916-B644-95C5FC4547DAQ37855867-0E319A60-5A79-4A90-B315-DDD74B239103Q38006608-5DC1D9BA-615D-4510-918E-6C2C3B9D2E40Q38105519-5897FB6F-935C-4B1D-8F25-809E45C31EF6Q38115293-7782C387-9203-41D6-B899-27B6DA78BCAAQ39330520-D15B8AE6-6447-4F89-B247-A3981D0B9E4AQ39619012-8A4CF456-AC30-4C04-8248-7642AB4917E5Q39998466-A01CB233-D73D-494E-B684-31CD429F6869Q41575117-6F59269C-809A-40BB-A7B2-B380C31549E2Q41874393-CDA7D21C-D8DB-4647-B13A-798214849E33Q49196357-5B9B9CE9-4C62-42CA-BDC6-EAB4FB8B33A1Q51741120-F925876F-E113-4E58-8566-773DFD58A07A
P2860
Nitric oxide (NO)- and nitroxyl (HNO)-generating diazeniumdiolates (NONOates): emerging commercial opportunities.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Nitric oxide (NO)- and nitroxy ...... ging commercial opportunities.
@ast
Nitric oxide (NO)- and nitroxy ...... ging commercial opportunities.
@en
type
label
Nitric oxide (NO)- and nitroxy ...... ging commercial opportunities.
@ast
Nitric oxide (NO)- and nitroxy ...... ging commercial opportunities.
@en
prefLabel
Nitric oxide (NO)- and nitroxy ...... ging commercial opportunities.
@ast
Nitric oxide (NO)- and nitroxy ...... ging commercial opportunities.
@en
P356
P1476
Nitric oxide (NO)- and nitroxy ...... ging commercial opportunities.
@en
P2093
Larry K Keefer
P304
P356
10.2174/1568026054679380
P577
2005-01-01T00:00:00Z